Uganda’s Ministry of Health has announced an extension of Phase II of its vaccination campaign.
The decision announced on Monday evening by the PS Dr Diana Atwine, comes as a proactive measure to ensure the population is adequately protected against the deadly viral infection, as confirmed cases continue to emerge within the country.
Yellow Fever, a serious viral infection transmitted through mosquito bites, poses a significant public health threat, with symptoms including fever, jaundice, and bleeding from various body openings. Recent cases in Wakiso and Buikwe serve as stark reminders of the urgent need for widespread vaccination.
Phase II of the Yellow Fever Vaccination Campaign, initially slated to conclude on April 8th, 2024, will now be extended until April 14th, 2024. This extension aims to reach more individuals in regions identified as high-risk areas, including Karamoja, Teso, Masaka, Ankole, and Kampala Metropolitan.
Dr. Atwine, emphasized the importance of achieving a vaccination rate of at least 80% of the population to minimize the risk of outbreaks. She urged parents to consent to their children’s vaccination and called upon religious, cultural, and political leaders to mobilize their communities to participate in the campaign.
The Yellow Fever vaccine, introduced into Uganda’s routine immunization program in October 2022, has been made accessible to the population free of charge during the campaign. However, after the national rollout concludes, individuals above one year old will be required to pay for the vaccine, underscoring the importance of taking advantage of the ongoing campaign.
Furthermore, the Ministry of Health addressed concerns about the accessibility and authenticity of Yellow Fever vaccination booklets, noting instances of forgery for travel purposes. To mitigate this issue, vaccination cards issued during the campaign can be presented at accredited health facilities to obtain a valid Yellow Fever vaccination booklet for travel at a minimal cost.
The Ministry reassured the public of the safety and effectiveness of the Yellow Fever vaccine, emphasizing its lifelong protection against the disease. Dr. Atwine expressed gratitude to all participants and stakeholders involved in the campaign and urged continued support to combat the spread of Yellow Fever in Uganda.
